No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9881400 |
chr3:135861666-135861667 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs555440105 |
chr3:135861692-135861693 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs375924171 |
chr3:135861696-135861697 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs557014142 |
chr3:135861699-135861700 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs370035579 |
chr3:135861730-135861731 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs568345693 |
chr3:135861750-135861751 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs78248315 |
chr3:135861751-135861752 |
Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs572279825 |
chr3:135861817-135861818 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs188844458 |
chr3:135861851-135861852 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs539120852 |
chr3:135861872-135861873 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs138158437 |
chr3:135861877-135861878 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs562840283 |
chr3:135861888-135861889 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs572551859 |
chr3:135861942-135861943 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs143517444 |
chr3:135861964-135861965 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs147173443 |
chr3:135861969-135861970 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs541203362 |
chr3:135861972-135861973 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs575501236 |
chr3:135861984-135861985 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs193290330 |
chr3:135862021-135862022 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148603886 |
chr3:135862129-135862130 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs571485709 |
chr3:135862152-135862153 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs540937978 |
chr3:135862163-135862164 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs141157687 |
chr3:135862168-135862169 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs546822685 |
chr3:135862197-135862198 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs116729096 |
chr3:135862206-135862207 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs527547875 |
chr3:135862299-135862300 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs150681650 |
chr3:135862322-135862323 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs562902482 |
chr3:135862355-135862356 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs139990584 |
chr3:135862357-135862358 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs543017453 |
chr3:135862461-135862462 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs530777788 |
chr3:135862484-135862485 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs550760019 |
chr3:135862496-135862497 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs530425604 |
chr3:135862501-135862502 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs547723506 |
chr3:135862536-135862537 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs539617135 |
chr3:135862539-135862540 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs6765530 |
chr3:135862546-135862547 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs566216349 |
chr3:135862564-135862565 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs184631981 |
chr3:135862568-135862569 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs563041093 |
chr3:135862612-135862613 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs554917637 |
chr3:135862620-135862621 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs187531801 |
chr3:135862623-135862624 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs560108357 |
chr3:135862643-135862644 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs113799200 |
chr3:135862651-135862652 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs532115427 |
chr3:135862690-135862691 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs146844070 |
chr3:135862707-135862708 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs192057983 |
chr3:135862761-135862762 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs567222802 |
chr3:135862780-135862781 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs75216765 |
chr3:135862845-135862846 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs184026368 |
chr3:135862878-135862879 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs189671398 |
chr3:135862889-135862890 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs529377067 |
chr3:135862890-135862891 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|